Chengdu Kanghong Pharmaceutical Group Co., Ltd Stock: price and insider trades · China
康弘药业
No insider purchase over the last 90 days. The latest, by 柯潇, was filed 03 Mar 2023.
Chengdu Kanghong Pharmaceutical Group Co., Ltd: what insiders have been doing
Chengdu Kanghong Pharmaceutical Group Co., Ltd is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Chengdu Kanghong Pharmaceutical Group Co., Ltd. The previous disclosure was published on 3 March 2023.
Since 2021, the database holds 3 purchases and no sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- -2.3%Entry CN¥18.02 · Close at T+365 CN¥17.60
- -39.4%Entry CN¥23.68 · Close at T+365 CN¥14.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 22,800 shares2.0% of flowA股XSHESZSE:173000006337090500Canonical exit: 1 Jun 2023 (T+90)
- 27,000 shares100.0% of flowA股XSHESZSE:173000005365392960Canonical exit: 31 Aug 2021 (T+90)
- 1,000,000 shares98.0% of flowA股XSHESZSE:173000004413944960Canonical exit: 17 Aug 2021 (T+90)
3 of 3 declarations
About Chengdu Kanghong Pharmaceutical Group Co., Ltd
康弘药业 is a company specializing in the health and pharmaceutical sector, offering a range of pharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
